oncology
Medicines

New advice on creatinine rises with ribociclib

Elevated creatinine with ribociclib is not always a sign of kidney impairment and should not necessarily lead to stopping therapy, Australian clinicians say. Creatinine eleveations were seen in 28% of patients being treated with the CDK4/6 inhibitor for hormone receptor positive metastatic breast cancer at NSW centres.   A retrospective study of all 32 patients treated ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic